UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 147

Sortiert nach

Duration of ≥MR4 Is the Best Predictor for a Successful 1st Treatment-Free Remission (TRF1) Attempt in CML Patients Treated with Tyrosine Kinase Inhibitors (TKI); Long-Term Follow-up of a Large Cohort of Patients Including a Cohort Undergoing a 2nd Tfr (TFR2) Attempt

Blood, 2022-11, Vol.140 (Supplement 1), p.3900-3901

2022

Volltextzugriff (PDF)

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

Blood, 2013-07, Vol.122 (4), p.515-522

2013

Volltextzugriff (PDF)

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

The lancet oncology, 2016-01, Vol.17 (1), p.27-38

2016

Volltextzugriff (PDF)

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

The Lancet infectious diseases, 2013-06, Vol.13 (6), p.519-528

2013

Volltextzugriff (PDF)

Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response

Thrombosis and haemostasis, 2019-07, Vol.119 (7), p.1112

2019

Volltextzugriff (PDF)

Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?

Experimental hematology, 2015-03, Vol.43 (3), p.149-157

2015

Volltextzugriff (PDF)

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia

British journal of haematology, 2021-03, Vol.192 (6), p.1026-1030

2021

Volltextzugriff (PDF)

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

The Journal of clinical investigation, 2019-10, Vol.129 (10), p.4451-4463

2019

Volltextzugriff (PDF)

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

Leukemia, 2018-12, Vol.32 (12), p.2572-2579

2018

Volltextzugriff (PDF)

Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib

Blood, 2014-07, Vol.124 (5), p.729-736

2014

Volltextzugriff (PDF)

NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation

Leukemia research, 2016-04, Vol.43, p.58-65

2016

Volltextzugriff (PDF)

Telomerase in cancer immunotherapy

Biochimica et biophysica acta, 2010, Vol.1805 (1), p.35-42

2010

Volltextzugriff (PDF)

Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells

The Journal of biological chemistry, 2013-03, Vol.288 (12), p.8679-8690

2013

Volltextzugriff (PDF)

Bisphosphonate‐associated osteonecrosis of the auditory canal

British journal of haematology, 2006-01, Vol.132 (1), p.114-114

2006

Volltextzugriff (PDF)

Outcomes of non‐myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission

Internal medicine journal, 2021-11, Vol.51 (11), p.1954-1958

2021

Volltextzugriff (PDF)

The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation

Leukemia research, 2013-05, Vol.37 (5), p.516-519

2013

Volltextzugriff (PDF)

Enhanced Immune System Regeneration in Humans Following Allogeneic or Autologous Hemopoietic Stem Cell Transplantation by Temporary Sex Steroid Blockade

Clinical cancer research, 2008-02, Vol.14 (4), p.1138-1149

2008

Volltextzugriff (PDF)

Adaptive reprogramming of NK cells in X-linked lymphoproliferative syndrome

Blood, 2018-02, Vol.131 (6), p.699-702

2018

Volltextzugriff (PDF)

NK cell maturation to CD56dim subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation

Leukemia research, 2016-04, Vol.43, p.58-65

2016

Volltextzugriff (PDF)

Acute graft-versus-host disease associated cerebellitis as the cause of pyrexia of unknown origin detected with 18F-FDG-PET/CT

Cancer treatment and research communications, 2021, Vol.27, p.100341-100341, Article 100341

2021

Volltextzugriff (PDF)

Ex vivo expansion of CD3depleted cord blood-MNCs in the presence of bone marrow stromal cells; an appropriate strategy to provide functional NK cells applicable for cellular therapy

Stem cell research, 2017-03, Vol.19, p.148-155

2017

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(147)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Humans
(75)
Hematology
(50)
Male
(47)
Female
(45)
Adult
(40)
Middle Aged
(39)
Oncology
(26)
Biological And Medical Sciences
(24)
Medical Sciences
(23)
Adolescent
(19)
Treatment Outcome
(18)
Aged
(16)
Hematopoietic Stem Cell Transplantation
(12)
Immunology
(12)
Retrospective Studies
(12)
Disease-Free Survival
(11)
Hematologic And Hematopoietic Diseases
(11)
Transplantation, Homologous
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Duration of ≥MR4 Is the Best Predictor for a Successful 1st Treatment-Free Remission (TRF1) Attempt in CML Patients Treated with Tyrosine Kinase Inhibitors (TKI); Long-Term Follow-up of a Large Cohort of Patients Including a Cohort Undergoing a 2nd Tfr (TFR2) Attempt

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response

Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib

Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets

NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

Telomerase in cancer immunotherapy

Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells

Bisphosphonate‐associated osteonecrosis of the auditory canal

Outcomes of non‐myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission

The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation

Enhanced Immune System Regeneration in Humans Following Allogeneic or Autologous Hemopoietic Stem Cell Transplantation by Temporary Sex Steroid Blockade

Adaptive reprogramming of NK cells in X-linked lymphoproliferative syndrome

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy

NK cell maturation to CD56dim subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation

Acute graft-versus-host disease associated cerebellitis as the cause of pyrexia of unknown origin detected with 18F-FDG-PET/CT

Ex vivo expansion of CD3depleted cord blood-MNCs in the presence of bone marrow stromal cells; an appropriate strategy to provide functional NK cells applicable for cellular therapy

Suchergebnisse filtern